Related Experiment Video
Updated: Oct 24, 2025

Catheter Ablation in Combination With Left Atrial Appendage Closure for Atrial Fibrillation
Published on: February 26, 2013
A Patient Decision Aid for Anticoagulation Therapy in Patients With Nonvalvular Atrial Fibrillation: Development and
Kim Paul de Castro1, Harold Henrison Chiu1, Ronna Cheska De Leon-Yao1
1Department of Medicine, Philippine General Hospital, University of the Philippines, Manila, Philippines.
A new mobile app-based patient decision aid (PDA) for atrial fibrillation (AF) effectively reduced decisional conflict and improved knowledge regarding oral anticoagulants for stroke prevention. The PDA was well-received by both patients and physicians in the pilot study.
Area of Science:
- Cardiology
- Health Informatics
- Patient Decision Making
Background:
- Atrial fibrillation (AF) is a major risk factor for ischemic stroke, necessitating anticoagulant therapy.
- Choosing among oral anticoagulants presents a challenge for patients due to multiple options.
- Patient decision aids (PDAs) can enhance informed decision-making, but culturally relevant tools are scarce.
Purpose of the Study:
- To develop and pilot test a mobile app-based PDA for patients with nonvalvular AF.
- To assess the PDA's impact on patient decisional conflict and knowledge.
- To evaluate patient and physician acceptability of the PDA.
Main Methods:
- Developed a mobile app-based PDA following IPDAS guidelines.
- Incorporated patient-identified decisional needs into the PDA's comparison features.
- Pilot tested the PDA with 30 physicians and 37 patients, measuring decisional conflict and knowledge before and after use.
Main Results:
- The PDA compared anticoagulant options based on stroke risk, bleeding risk, and price.
- Patient decisional conflict scores decreased significantly (35 points, P<.001).
- Patient knowledge scores improved significantly (from 10 to 15, P<.001), with high acceptability among patients and physicians.
Conclusions:
- An app-based PDA effectively reduced decisional conflict and improved knowledge for nonvalvular AF patients choosing anticoagulants.
- The PDA demonstrated acceptability and utility in the local setting.
- Further randomized controlled trials are recommended to confirm effectiveness against usual care.
Related Concept Videos
Venous Thrombosis III: Interprofessional Care
Anticoagulant Drugs: Vitamin K Antagonists and Direct Oral Anticoagulants
Warfarin, a prominent vitamin K antagonist family member, exerts its effect by inhibiting the enzyme VKORC1 (vitamin K epoxide reductase complex 1). By hindering this enzyme, warfarin...
Pulmonary Embolism II: Diagnostic Studies and Interprofessional Care
Acute Coronary Syndrome III: Diagnostic Studies
Peripheral Artery Disease III: Interprofessional Care

